P284 Inflammatory bowel disease nursing: Results of an audit exploring the roles, responsibilities and activity of nurses with specialist/advanced roles within inflammatory bowel disease

Mason, Isobel; Holbrook, K.; Garrick, Vikki; Johns, K.; Kane, Maureen; Kemp, Karen

doi:10.1016/s1873-9946(12)60304-3

Cited by 4 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, nurses should develop a constructive and empathic approach to special situations such as fistula, incontinence, sexuality, pregnancy and fertility, pain, fatigue. In order for nurses to fulfill these tasks successfully, they must be seen as part of a multidisciplinary team [14][15][16][17]. There are also some important topics in the job description of the nursing staff: providing nutritional support, performing training and counseling roles, defining and developing IBD services.…”

Section: Introductionmentioning

confidence: 99%

Nursing at Inflammatory Bowel Diseases

Uran¹

2017

ARGH

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Nursing at Inflammatory Bowel Diseases

Uran¹

2017

ARGH

View full text Add to dashboard Cite

Identification of Research Priorities for Inflammatory Bowel Disease Nursing in Europe: a Nurses-European Crohn’s and Colitis Organisation Delphi Survey

Dibley

Bager

Czuber‐Dochan

et al. 2016

ECCOJC

View full text Add to dashboard Cite

Aligning oral mesalazine treatment to health service priorities: guidance for nurses

Kemp

Sephton

2013

Frontline Gastroenterol

View full text Add to dashboard Cite

Oral mesalazine represents a crucial front-line agent for the treatment of active ulcerative colitis (UC) and the maintenance of remission. Clinical aspects of mesalazine therapy are guided by robust evidence-based guidelines, although there is a relative paucity of guidance examining the specific administrative and professional issues faced by inflammatory bowel disease (IBD) nurses. As IBD nurses frequently influence treatment decisions in UC, this article was written to provide a practical review of the key evidence and issues affecting mesalazine treatment. Therefore, it may act as an additional resource for IBD nurses, to enhance prescribing decisions. Using the UK's Quality, Innovation, Productivity and Prevention (QIPP) agenda as a framework, it considers clinical and health service priorities affecting treatment decisions. The quality of care perspective naturally focuses on efficacy; recent interest in specific aspects of efficacy, such as the speed of symptom resolution allows targeting of mesalazine treatment to individual needs. Furthermore, innovative adherence programmes build on the latest evidence to develop robust, integrated patient support approaches. In terms of productivity, nurse-led activities and more sophisticated management strategies may offer the best routes towards reducing the costs of care. Key opportunities for preventing ill health include improving adherence to maintenance therapy and achieving mucosal healing. The principles and approaches highlighted by the QIPP agenda emphasise that prescribing decisions for mesalazine in UC must take account of the full spectrum of clinical and health service needs, and cannot focus on any one element in isolation.

show abstract

P284 Inflammatory bowel disease nursing: Results of an audit exploring the roles, responsibilities and activity of nurses with specialist/advanced roles within inflammatory bowel disease

Cited by 4 publications

References 0 publications

Nursing at Inflammatory Bowel Diseases

Nursing at Inflammatory Bowel Diseases

Identification of Research Priorities for Inflammatory Bowel Disease Nursing in Europe: a Nurses-European Crohn’s and Colitis Organisation Delphi Survey

Aligning oral mesalazine treatment to health service priorities: guidance for nurses

Contact Info

Product

Resources

About